'MGMT ProFWise: Unlocking a New App for Combined Feature Selection and the Rank-Based Weighting Method to Link MGMT Methylation Status to Serum Protein Expression in #Glioblastoma patients,' was published in IJMS MDPI by Yajas Shah and Olivier Elemento

mdpi.com/1422-0067/25/7…

Be sure and check out the conversation between The Rick Bangs, host of the #bladdercancermatters podcast Bladder Cancer Advocacy Network and our colleague Dr. Bishoy Faltas (@FaltasLab) the WCM Englander Institute for Precision Medicine's Chief Research Officer!

Don't miss WCM Englander Institute for Precision Medicine Clinical Director Dr. Cora Sternberg's (@cnsternberg) abstract, 'Feasibility of implementing whole genome sequencing into routine #oncology care,' with First Author Dr. Pashtoon Kasi (@pashtoonkasi) ASCO! #WGS #AACR24 #PrecisionMedicine

Don't miss Monday's WCM Englander Institute for Precision Medicine #PrecisionMedicine Research Conference with participation by Pashtoon Kasi MD, MS Cora Sternberg!

Monday, April 29, 11am-12pm. Belfer Research Building, Room 1401.

Don't miss WCM Englander Institute for Precision Medicine Clinical Director Dr. Cora Sternberg's (@cnsternberg) abstract 'Avelumab first-line maintenance for advanced #urothelialcarcinoma : long-term outcomes from #JAVELIN Bladder 100 in patients with low tumor burden,' ASCO! #AACR24 #PrecisionMedicine

Glad to share our recent Nature Communications comment on Patricia Boya recent work on #mitophagy and #aging . Kudos to first author Emma Guilbaud who did the heavy lifting and Kristopher Sarosiek! Available at rdcu.be/dFhzU Weill Cornell Medicine Meyer Cancer Center WCM Office of the Research Dean WCM Englander Institute for Precision Medicine Weill Cornell Medicine

IBC is a clinical diagnosis and the peculiar differences with other forms of breast cancer are related to the TME and the host. rdcu.be/dFkNL IBC Foundation Wendy Woodward MDPhD Cristofanilli CTC Laboratory

We enjoyed bringing everyone together for our 6th annual Diversity Week!

We celebrated our great community, welcomed special guests and shared insights on how to strive for excellence in medicine and continue building a culture of inclusion, equity, justice and belonging.

“The collaboration with WCM Englander Institute for Precision Medicine will explore and implement ways for comprehensive #riskassessment from our unique blood testing technology for patient treatment, health checks and screening programs for multiple common chronic diseases.”

longevity.technology/news/nightinga…

“These statistics can sound alarming but people need to know that #cancer medicine is evolving so rapidly, and we’re having breakthroughs literally every day,” said Dr. Allyson Ocean (Dr. Allyson Ocean ) New York Post NewYork-Presbyterian Weill Cornell Medicine WCM Englander Institute for Precision Medicine

nypost.com/2024/04/18/lif…

Saved me! Important information. All cancer patients need this and must ask their oncologists to do these simple blood tests.

💡Timing⏱️of assessing response to #immunotherapy matters.

We underestimate how quickly immunotherapy works.👇🏾1️⃣2️⃣days with BOT/BAL #NestTrial 🪺all you see are immune cells🟣🟣in the biopsy.

At surgery➡️tumor is💯% dead; immune cells have left the party.

📸 RareCyte, Inc. #CRCSM

I'm a #doctor — here's what to know about rising #cancer rates in young people nypost.com/2024/04/18/lif… via New York Post NewYork-Presbyterian Weill Cornell Medicine ASCO WCM GI Cancer WCM Englander Institute for Precision Medicine

One week from today! Our WCM Englander Institute for Precision Medicine Director Olivier Elemento, PhD (@ElementoLab) will speak on the 'Upcoming #AI revolution in #healthcare and #medicine ,' at the 'AI Meets Science' conference hosted by NYU Tandon

Don't miss the new OncLive.com interview with WCM Englander Institute for Precision Medicine's Dr. Scott T. Tagawa (@DrScottTagawa) on 'The Rationale for Investigating First-Line #Nivolumab Plus #Cisplatin in #UrothelialCancer . #PrecisionMedicine

onclive.com/view/dr-tagawa…

Our next #PrecisionMedicine Research Conference presents a Molecular Tumor Board of Two Rare Cancers. The first is a 69-year-old female with #metastatic high grade #neuroendocrine #carcinoma of the colon. Patient referred by WCM Englander Institute for Precision Medicine's Pashtoon Kasi MD, MS.

The second Rare Cancer presentation will focus on a 64-year-old female with metastatic squamous cell carcinoma of the bladder. Patient referred by our Clinical Director Dr. Cora Sternberg (Cora Sternberg), and presented by Dr. Daniela Guevara!

'Our precision #metabolomics pilot project marks the beginning of a new era in healthcare to tailor treatments uniquely for each patient, advancing #PrecisionMedicine to benefit patients globally,' EIPM Director Dr. Elemento (Olivier Elemento) to LabPulse.

labpulse.com/business-insig…

We hope you can join us a week from today for our next WCM Englander Institute for Precision Medicine Journal Club, presented by Olivier Elemento's Chengqi Xu (@ChengqiXu)! #LLMs

I enjoyed my conversation w Robert W. Yeh MD on how to produce high quality evidence regarding medical interventions and how we might think about what's required to have more useful observational data. theheartorg | Medscape BIDMC Smith Center Tricia Ward medscape.com/viewarticle/10…